HIGHResearchTier 1
Oncogenic role of human papillomavirus in oral and oropharyngeal cancers: molecular
SourceJournal of the American Dental Association (JADA)Tier 1Peer-Reviewed Research
Originally at sciencedirect.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Oral HPV testing and counseling now sit squarely in the dentist's lane; this JADA paper equips general dentists and specialists to identify oncogenic HPV-related lesions earlier and to document findings that affect both oncology referral and professional liability.
Key points
- The article synthesizes molecular pathways linking high-risk HPV genotypes to malignant transformation of oral and oropharyngeal mucosa.
- Authors outline chair-side red-flag criteria (persistent verrucous or ulcerative lesions, laterality, lymph-node involvement) for biopsy or referral.
- Clinical implications section stresses that dentists are often the first health-care providers to visualize these HPV-driven cancers, shifting diagnostic responsibility upstream.
- No effective date or implementation timeline is stated; the piece is a narrative review published online 29 September 2026.
Who should care
SpecialistAcademiaAssociate
Read the original on Journal of the American Dental Association (JADA)
Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.